Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2014, Article ID 157376, 12 pages
http://dx.doi.org/10.1155/2014/157376
Research Article

Propofol Inhibits Lipopolysaccharide-Induced Tumor Necrosis Factor-Alpha Expression and Myocardial Depression through Decreasing the Generation of Superoxide Anion in Cardiomyocytes

1Department of Anesthesiology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China
2Department of Orthopedics and Traumatology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China
3Department of Anesthesiology, The University of Hongkong Shenzhen Hospital, Shenzhen, Guangdong 518053, China

Received 18 April 2014; Accepted 16 July 2014; Published 11 August 2014

Academic Editor: Neelam Khaper

Copyright © 2014 Jing Tang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Liaudet, “Cardiovascular dysfunction in sepsis: from basic mechanisms to clinical management,” Current Vascular Pharmacology, vol. 11, no. 2, pp. 121–122, 2013. View at Google Scholar · View at Scopus
  2. A. J. Walkey, M. A. Greiner, S. R. Heckbert et al., “Atrial fibrillation among Medicare beneficiaries hospitalized with sepsis: incidence and risk factors,” American Heart Journal, vol. 165, no. 6, pp. 949–955, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Barkhausen, F. Hildebrand, C. Krettek, and M. van Griensven, “DHEA-dependent and organ-specific regulation of TNF-α mRNA expression in a murine polymicrobial sepsis and trauma model,” Critical Care, vol. 13, no. 4, article R114, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Kumar, A. Krieger, S. Symeoneides, A. Kumar, and J. E. Parrillo, “Myocardial dysfunction in septic shock: part II. Role of cytokines and nitric oxide,” Journal of Cardiothoracic and Vascular Anesthesia, vol. 15, no. 4, pp. 485–511, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Peng, X. Lu, M. Lei, G. W. Moe, and Q. Feng, “Inhibition of p38 MAPK decreases myocardial TNF-alpha expression and improves myocardial function and survival in endotoxemia,” Cardiovascular Research, vol. 59, no. 4, pp. 893–900, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. B. M. Babior, J. D. Lambeth, and W. Nauseef, “The neutrophil NADPH oxidase,” Archives of Biochemistry and Biophysics, vol. 397, no. 2, pp. 342–344, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Peng, X. Lu, and Q. Feng, “Pivotal role of gp91phox-containing NADH oxidase in lipopolysaccharide-induced tumor necrosis factor-α expression and myocardial depression,” Circulation, vol. 111, no. 13, pp. 1637–1644, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Hsing, M. Lin, P. Choi et al., “Anesthetic propofol reduces endotoxic inflammation by inhibiting reactive oxygen species-regulated Akt/IKKβ/NF-κB signaling,” PLoS ONE, vol. 6, no. 3, Article ID e17598, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Tang, P. Deng, Y. Jiang et al., “Role of HMGB1 in propofol protection of rat intestinal epithelial cells injured by heat shock,” Cell Biology International, vol. 37, no. 3, pp. 262–266, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Zhu, J. Chen, H. Jiang, and C. Miao, “Propofol protects against high glucose-induced endothelial adhesion molecules expression in human umbilical vein endothelial cells,” Cardiovascular Diabetology, vol. 12, no. 1, article 13, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. T. B. Corcoran, A. Engel, H. Sakamoto et al., “The effects of propofol on lipid peroxidation and inflammatory response in elective coronary artery bypass grafting,” Journal of Cardiothoracic and Vascular Anesthesia, vol. 18, no. 5, pp. 592–604, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Tang, X. Chen, W. Tu et al., “Propofol inhibits the activation of p38 through up-regulating the expression of Annexin A1 to exert its anti-inflammation effect,” PLoS ONE, vol. 6, no. 12, Article ID e27890, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. G.-J. Wu, Y.-T. Tai, T.-L. Chen, L.-L. Lin, Y.-F. Ueng, and R.-M. Chen, “Propofol specifically inhibits mitochondrial membrane potential but not complex I NADH dehydrogenase activity, thus reducing cellular ATP biosynthesis and migration of macrophages,” Annals of the New York Academy of Sciences, vol. 1042, pp. 168–176, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. X. Ma, Y. W. Hu, Z. L. Zhao et al., “Anti-inflammatory effects of propofol are mediated by apolipoprotein M in a hepatocyte nuclear factor-1α-dependent manner,” Archives of Biochemistry and Biophysics, vol. 533, no. 1-2, pp. 1–10, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Yu, P. Lui, T. L. Hwang, C. H. Yen, and Y. T. Lau, “Propofol improves endothelial dysfunction and attenuates vascular superoxide production in septic rats,” Critical Care Medicine, vol. 34, no. 2, pp. 453–460, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Zhang, X. Lu, F. Beier, and Q. Feng, “Rac1 activation induces tumour necrosis factor-α expression and cardiac dysfunction in endotoxemia,” Journal of Cellular and Molecular Medicine, vol. 15, no. 5, pp. 1109–1121, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Gao, B. X. Zeng, L. J. Zhou, and S. Y. Yuan, “Protective effects of early treatment with propofol on endotoxin-induced acute lung injury in rats,” British Journal of Anaesthesia, vol. 92, no. 2, pp. 277–279, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Wang, G. Wang, C. Wang, Y. Wei, Z. Wen, and A. Zhu, “The early stage formation of PI3K-AMPAR GluR2 subunit complex facilitates the long term neuroprotection induced by propofol post-conditioning in rats,” PLoS ONE, vol. 8, no. 6, Article ID e65187, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Jawan, Y.-H. Kao, S. Goto et al., “Propofol pretreatment attenuates LPS-induced granulocyte-macrophage colony-stimulating factor production in cultured hepatocytes by suppressing MAPK/ERK activity and NF-κB translocation,” Toxicology and Applied Pharmacology, vol. 229, no. 3, pp. 362–373, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. C. H. Hsing, Y. H. Chen, C. L. Chen et al., “Anesthetic propofol causes glycogen synthase kinase-3β-regulated lysosomal/mitochondrial apoptosis in macrophages,” Anesthesiology, vol. 116, no. 4, pp. 868–881, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. P. G. Murphy, D. S. Myers, M. J. Davies, N. R. Webster, and J. G. Jones, “The antioxidant potential of propofol (2,6-diisopropylphenol),” British Journal of Anaesthesia, vol. 68, no. 6, pp. 613–618, 1992. View at Publisher · View at Google Scholar · View at Scopus
  22. P. A. Ward and H. Gao, “Sepsis, complement and the dysregulated inflammatory response,” Journal of Cellular and Molecular Medicine, vol. 13, no. 10, pp. 4154–4160, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Peng, X. Lu, M. Lei, and Q. Feng, “Endothelial nitric-oxide synthase enhances lipopolysaccharide-stimulated tumor necrosis factor-α expression via cAMP-mediated p38 MAPK pathway in cardiomyocytes,” The Journal of Biological Chemistry, vol. 278, no. 10, pp. 8099–8105, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. G. J. Wu, T. L. Chen, C. C. Chang, and R. M. Chen, “Propofol suppresses tumor necrosis factor-α biosynthesis in lipopolysaccharide-stimulated macrophages possibly through downregulation of nuclear factor-kappa B-mediated toll-like receptor 4 gene expression,” Chemico-Biological Interactions, vol. 180, no. 3, pp. 465–471, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. C. M. Tsao, S. T. Ho, A. Chen, J. J. Wang, S. K. Tsai, and C. C. Wu, “Propofol ameliorates liver dysfunction and inhibits aortic superoxide level in conscious rats with endotoxic shock,” European Journal of Pharmacology, vol. 477, no. 2, pp. 183–193, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Octavia, H. P. Brunner-La Rocca, and A. L. Moens, “NADPH oxidase-dependent oxidative stress in the failing heart: from pathogenic roles to therapeutic approach,” Free Radical Biology & Medicine, vol. 52, no. 2, pp. 291–297, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. R. S. Frey, M. Ushio-Fukai, and A. B. Malik, “NADPH oxidase-dependent signaling in endothelial cells: role in physiology and pathophysiology,” Antioxidants & Redox Signaling, vol. 11, no. 4, pp. 791–810, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Kapadia, J. Lee, G. Torre-Amione, H. H. Birdsall, T. S. Ma, and D. L. Mann, “Tumor necrosis factor-α gene and protein expression in adult feline myocardium after endotoxin administration,” The Journal of Clinical Investigation, vol. 96, no. 2, pp. 1042–1052, 1995. View at Publisher · View at Google Scholar · View at Scopus
  29. U. Grandel, L. Fink, A. Blum et al., “Endotoxin-induced myocardial tumor necrosis factor-α synthesis depresses contractility of isolated rat hearts: evidence for a role of sphingosine and cyclooxygenase-2-derived thromboxane production,” Circulation, vol. 102, no. 22, pp. 2758–2764, 2000. View at Google Scholar · View at Scopus
  30. X. Ye, Q. Lian, M. F. Eckenhoff, R. G. Eckenhoff, and J. Z. Pan, “Differential general anesthetic effects on microglial cytokine expression,” PLoS ONE, vol. 8, no. 1, Article ID e52887, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Sun, L. Wang, J. Shen, Z. Wang, and Y. Qian, “Effect of propofol on mucous permeability and inflammatory mediators expression in the intestine following traumatic brain injury in rats,” Cytokine, vol. 40, no. 2, pp. 151–156, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. P. A. Ward, “New approaches to the study of sepsis,” EMBO Molecular Medicine, vol. 4, no. 12, pp. 1234–1243, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Tang, Y. Sun, W. K. K. Wu et al., “Propofol lowers serum PF4 level and partially corrects hypercoagulopathy in endotoxemic rats,” Biochimica et Biophysica Acta: Proteins and Proteomics, vol. 1804, no. 9, pp. 1895–1901, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. O. Fourcade, M. F. Simon, L. Litt, K. Samii, and H. Chap, “Propofol inhibits human platelet aggregation induced by proinflammatory lipid mediators,” Anesthesia and Analgesia, vol. 99, no. 2, pp. 393–398, 2004. View at Google Scholar · View at Scopus